Schauenburg H, Sammet I, Strack M
Klinik und Poliklinink für Psychosomatik und Psychotherapie, Georg-August-Universität, Göttingen, Germany.
Z Psychosom Med Psychother. 2001;47(4):380-95. doi: 10.13109/zptm.2001.47.4.380.
The study looks for typical curves of symptom development in inpatients and investigates the influence of initial remoralisation and terminal improvement on the global therapy outcome.
71 psychotherapy inpatients (affective, anxiety, eating and personality disorders; average treatment duration 11.9 weeks) gave weekly self-reports on symptom severity (BSI, Derogatis, 1983) and had a complete outcome evaluation. Regression parameters of the symptom curves were taken for correlational and path analytic calculations.
Initial symptom alleviation is able to predict better global outcome. However there is a relevant subgroup of patients which has a good outcome despite an initial deterioration.
Initial remoralisation predicts better outcome but is not a necessary condition. The results partly call into question the group statistical "dose-response-curves". Further studies should test the influence of other process parameters (group cohesion, therapeutic alliance etc.) on the course of treatment.
本研究旨在探寻住院患者症状发展的典型曲线，并探究初始症状改善和末期改善对整体治疗效果的影响。
71名接受心理治疗的住院患者（情感障碍、焦虑症、饮食障碍和人格障碍；平均治疗时长11.9周）每周汇报症状严重程度（症状自评量表，德罗加蒂斯，1983年），并进行全面的疗效评估。采用症状曲线的回归参数进行相关性和路径分析计算。
初始症状缓解能够更好地预测整体疗效。然而，有一个相关的患者亚组，尽管初始症状恶化，但仍取得了良好的疗效。
初始症状改善预示着更好的疗效，但并非必要条件。研究结果部分地质疑了群体统计学上的“剂量反应曲线”。进一步的研究应测试其他过程参数（群体凝聚力、治疗联盟等）对治疗进程的影响。
